P, M., A, H., D, A., M, N., W, G., EA, T., . . . M, E. (2025). A thorough clinical study pipeline to discover and validate biomarkers in kidney transplantation: The European BIOMARGIN program. Journal of pharmaceutical and biomedical analysis, 263, 116911. https://doi.org/10.1016/j.jpba.2025.116911
Chicago Style (17th ed.) CitationP, Marquet, Humeau A, Anglicheau D, Naesens M, Gwinner W, Thevenot EA, Labriffe M, and Essig M. "A Thorough Clinical Study Pipeline to Discover and Validate Biomarkers in Kidney Transplantation: The European BIOMARGIN Program." Journal of Pharmaceutical and Biomedical Analysis 263 (2025): 116911. https://doi.org/10.1016/j.jpba.2025.116911.
MLA (9th ed.) CitationP, Marquet, et al. "A Thorough Clinical Study Pipeline to Discover and Validate Biomarkers in Kidney Transplantation: The European BIOMARGIN Program." Journal of Pharmaceutical and Biomedical Analysis, vol. 263, 2025, p. 116911, https://doi.org/10.1016/j.jpba.2025.116911.